These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2442273)

  • 41. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR
    Science; 1989 Jun; 244(4908):1072-5. PubMed ID: 2471266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitating presentation of MHC class I-restricted antigens.
    Chen W; Bennink JR; Yewdell JW
    Methods Mol Biol; 2001; 156():245-54. PubMed ID: 11068765
    [No Abstract]   [Full Text] [Related]  

  • 43. A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro.
    Berkhoff EG; Boon AC; Nieuwkoop NJ; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2004 May; 78(10):5216-22. PubMed ID: 15113903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measles virus antigens induce both type-specific and canine distemper virus cross-reactive cytotoxic T lymphocytes in mice: localization of a common Ld-restricted nucleoprotein epitope.
    Beauverger P; Buckland R; Wild TF
    J Gen Virol; 1993 Nov; 74 ( Pt 11)():2357-63. PubMed ID: 7504072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity.
    Ulmer JB; Deck RR; DeWitt CM; Fu TM; Donnelly JJ; Caulfield MJ; Liu MA
    Vaccine; 1997 Jun; 15(8):839-41. PubMed ID: 9234528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.
    Fu TM; Ulmer JB; Caulfield MJ; Deck RR; Friedman A; Wang S; Liu X; Donnelly JJ; Liu MA
    Mol Med; 1997 Jun; 3(6):362-71. PubMed ID: 9234241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influenza A specific cytotoxic T-cell clones that do not recognize viral glycoproteins.
    Townsend AR; Skehel JJ
    Nature; 1982 Dec; 300(5893):655-7. PubMed ID: 6183597
    [No Abstract]   [Full Text] [Related]  

  • 48. Synthetic recombinant vaccines against viral agents.
    Arnon A; Levi R
    Int Arch Allergy Immunol; 1995 Dec; 108(4):321-6. PubMed ID: 7580302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast.
    Falk K; Rötzschke O; Deres K; Metzger J; Jung G; Rammensee HG
    J Exp Med; 1991 Aug; 174(2):425-34. PubMed ID: 1713253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained.
    Wherry EJ; Puorro KA; Porgador A; Eisenlohr LC
    J Immunol; 1999 Oct; 163(7):3735-45. PubMed ID: 10490969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of influenza A virus cross-reactive cytotoxic T cells by a nucleoprotein/haemagglutinin preparation.
    Wraith DC; Askonas BA
    J Gen Virol; 1985 Jun; 66 ( Pt 6)():1327-31. PubMed ID: 3874261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recognition of oligonucleotide-encoded T cell epitopes introduced into a gene unrelated to the original antigen.
    Chimini G; Pala P; Sire J; Jordan BR; Maryanski JL
    J Exp Med; 1989 Jan; 169(1):297-302. PubMed ID: 2462610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Viral hemagglutinin augments peptide-specific cytotoxic T cell responses.
    Ertel C; Millar NS; Emmerson PT; Schirrmacher V; von Hoegen P
    Eur J Immunol; 1993 Oct; 23(10):2592-6. PubMed ID: 8405059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The T cell receptor from an influenza-A specific murine CTL clone.
    Palmer MS; Bentley A; Gould K; Townsend AR
    Nucleic Acids Res; 1989 Mar; 17(6):2353. PubMed ID: 2784852
    [No Abstract]   [Full Text] [Related]  

  • 55. Efficacy of influenza haemagglutinin and nucleoprotein as protective antigens against influenza virus infection in mice.
    Andrew ME; Coupar BE
    Scand J Immunol; 1988 Jul; 28(1):81-5. PubMed ID: 2456608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Limiting dilution analysis of memory cytotoxic T lymphocytes specific for individual influenza virus gene products.
    Wysocka M; Bennink JR
    Cell Immunol; 1988 Apr; 112(2):425-9. PubMed ID: 3258552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection.
    Tite JP; Hughes-Jenkins C; O'Callaghan D; Dougan G; Russell SM; Gao XM; Liew FY
    Immunology; 1990 Oct; 71(2):202-7. PubMed ID: 2172156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo longitudinal analysis of a dominant TCR repertoire selected in human response to influenza virus.
    Prevost-Blondel A; Lengagne R; Letourneur F; Pannetier C; Gomard E; Guillet JG
    Virology; 1997 Jun; 233(1):93-104. PubMed ID: 9201219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo administration of major histocompatibility complex class I-specific peptides from influenza virus induces specific cytotoxic T cell hyporesponsiveness.
    Müllbacher A; Tha Hla R
    Eur J Immunol; 1993 Oct; 23(10):2526-31. PubMed ID: 8405053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A region of the influenza A/NT/60/68 PB2 protein containing an antigenic determinant recognized by murine H-2Dd restricted cytotoxic T lymphocytes.
    Reay PA; Jones IM; Brownlee GG
    Virology; 1988 Nov; 167(1):261-8. PubMed ID: 2460995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.